trimethadione has been researched along with Cancer of Pancreas in 2 studies
Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noda, A | 2 |
| Kamiya, N | 1 |
| Takayama, T | 1 |
| Hayakawa, T | 2 |
| Toda, Y | 1 |
| Nakajima, S | 1 |
| Suzuki, T | 1 |
1 review available for trimethadione and Cancer of Pancreas
| Article | Year |
|---|---|
[Diagnosis of pancreatic diseases: Biochemical tests].
Topics: Anticonvulsants; Cholecystokinin; Chronic Disease; Humans; Oxazoles; Pancreas; Pancreatic Cyst; Panc | 1973 |
1 other study available for trimethadione and Cancer of Pancreas
| Article | Year |
|---|---|
Pancreatolithiasis and pancreatic carcinoma. Evaluation of pancreatic excretion test with 5,5-dimethyl-2,4-oxazolidinedione.
Topics: Calculi; Cholecystokinin; Dimethadione; Duodenum; Humans; Oxazoles; Pancreatic Diseases; Pancreatic | 1977 |